Ignite Creation Date:
2025-12-25 @ 5:01 AM
Ignite Modification Date:
2025-12-26 @ 4:02 AM
Study NCT ID:
NCT00287118
Status:
COMPLETED
Last Update Posted:
2018-04-03
First Post:
2006-02-02
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Multicentre, Open Label Phase IIIb/IV Study of Subcutaneously Administered Raptiva in the Treatment of Adult Subjects With Moderate to Severe Plaque Psoriasis
Sponsor:
Merck KGaA, Darmstadt, Germany
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-10-27
Start Date Type:
ACTUAL
Primary Completion Date:
2006-05-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-05-30
Completion Date Type:
ACTUAL
First Submit Date:
2006-02-02
First Submit QC Date:
None
Study First Post Date:
2006-02-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-08-29
Results First Submit QC Date:
None
Results First Post Date:
2018-04-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-29
Last Update Post Date:
2018-04-03
Last Update Post Date Type:
ACTUAL